NO20032199D0 - Forebyggelse av tilbakevendende virussykdom - Google Patents

Forebyggelse av tilbakevendende virussykdom

Info

Publication number
NO20032199D0
NO20032199D0 NO20032199A NO20032199A NO20032199D0 NO 20032199 D0 NO20032199 D0 NO 20032199D0 NO 20032199 A NO20032199 A NO 20032199A NO 20032199 A NO20032199 A NO 20032199A NO 20032199 D0 NO20032199 D0 NO 20032199D0
Authority
NO
Norway
Prior art keywords
prevention
viral disease
recurrent viral
recurrent
disease
Prior art date
Application number
NO20032199A
Other languages
English (en)
Other versions
NO20032199L (no
Inventor
Laure Aurelian
Takahiro Gyotoku
Gary Jim Calton
Original Assignee
Aurx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurx Inc filed Critical Aurx Inc
Publication of NO20032199D0 publication Critical patent/NO20032199D0/no
Publication of NO20032199L publication Critical patent/NO20032199L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20032199A 2000-11-16 2003-05-15 Forebyggelse av tilbakevendende virussykdom NO20032199L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24938700P 2000-11-16 2000-11-16
PCT/US2001/043783 WO2003034981A2 (en) 2000-11-16 2001-11-16 Prevention of recurrent viral disease

Publications (2)

Publication Number Publication Date
NO20032199D0 true NO20032199D0 (no) 2003-05-15
NO20032199L NO20032199L (no) 2003-07-16

Family

ID=22943256

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032199A NO20032199L (no) 2000-11-16 2003-05-15 Forebyggelse av tilbakevendende virussykdom

Country Status (8)

Country Link
US (3) US20040220076A1 (no)
EP (1) EP1370283A4 (no)
JP (1) JP2005510489A (no)
KR (1) KR20030083682A (no)
AU (1) AU2002249764A1 (no)
CA (1) CA2429505A1 (no)
NO (1) NO20032199L (no)
WO (1) WO2003034981A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1906871A4 (en) * 2005-06-20 2010-01-27 Otologics Llc PLACING AN IMPLANTABLE MICROPHONE ON SOFT TISSUE
ES2732815T3 (es) 2009-05-22 2019-11-26 Genocea Biosciences Inc Vacunas frente al virus del herpes simple de tipo 2: composiciones y métodos para provocar una respuesta inmunitaria
EP2643014A4 (en) 2010-11-24 2015-11-11 Genocea Biosciences Inc HERPES SIMPLEX TYPE 2 VIRUS VACCINES: COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
US9624273B2 (en) 2011-11-23 2017-04-18 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CA2976268C (en) 2015-02-26 2021-07-06 Squarex, Llc Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
EP3519427A4 (en) 2016-09-28 2020-03-11 Genocea Biosciences Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US6013268A (en) * 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US6013265A (en) * 1996-10-22 2000-01-11 University Of Maryland, Baltimore Vaccine composition for herpes simplex virus and methods of using
WO1999036087A1 (en) * 1998-01-20 1999-07-22 Aurx, Inc. Novel vaccine compositions for herpes simplex virus
AU2231399A (en) * 1998-01-20 1999-08-02 Aurx, Inc. A herpes virus vector

Also Published As

Publication number Publication date
NO20032199L (no) 2003-07-16
EP1370283A2 (en) 2003-12-17
WO2003034981A2 (en) 2003-05-01
CA2429505A1 (en) 2003-05-01
US20040220076A1 (en) 2004-11-04
KR20030083682A (ko) 2003-10-30
JP2005510489A (ja) 2005-04-21
AU2002249764A1 (en) 2003-05-06
WO2003034981A3 (en) 2003-10-09
US20020094337A1 (en) 2002-07-18
EP1370283A4 (en) 2004-12-15
US20110059134A1 (en) 2011-03-10

Similar Documents

Publication Publication Date Title
AR028567A1 (es) Nuevos derivados de fenil-propargileter
AR028596A1 (es) Nuevos derivados de fenilglicina
NO20035522D0 (no) Kinuklidin-substituerte multisykliske heteroaryler for behandling av sykdom
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
PT1210113E (pt) Composicoes de vacinas de combinacao
NO20030134D0 (no) Fremstilling av olefinderivater
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
ID30187A (id) Dongkrak jenis pantagraf
ID30590A (id) Celana sekali pakai jenis-celana pendek
DE60118469D1 (de) Keramisches tragwerk
EE05020B1 (et) Glburiidi ravimkoostis
NO20034127D0 (no) Forbedring av aromainneholdende bestanddeler
DE60126814D1 (de) Inhalation von stickoxid
NO20030239D0 (no) Modifisert virus
NO20041968L (no) Anvendelse av cystationin
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
NO20025423D0 (no) FremgangsmÕte for fremstilling av Citalopram
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
NO20032199D0 (no) Forebyggelse av tilbakevendende virussykdom
DE60031450D1 (de) Polymorph v von torasemid
ITMO20000108A0 (it) Trappola per muridi
AR028070A1 (es) Sintesis de compuestos de ciclohexendimetanol o ciclohexandimetanol
DE60007360T2 (de) Amorphe modifikation von torasemid
NO20010590D0 (no) Syklon
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application